These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3092784)

  • 1. Detection of HTLV-III/LAV antigens in peripheral blood lymphocytes from patients with AIDS.
    Pekovic DD; Chausseau JP; Lapointe N; Michaud J; Garzon S; Strykowski H; Tsoukas C; Gilmore N; Goldman H; Gornitsky M
    Arch Virol; 1986; 91(1-2):11-9. PubMed ID: 3092784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enumeration of the T4 positive and T8 positive lymphocytes in AIDS and related syndromes. Comparison of the immunogold and the immunofluorescence techniques.
    Chollet-Martin S; Gougerot-Pocidalo MA
    J Immunol Methods; 1986 Jul; 91(2):271-4. PubMed ID: 3090151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
    De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
    Tschachler E; Groh V; Popovic M; Mann DL; Konrad K; Safai B; Eron L; diMarzo Veronese F; Wolff K; Stingl G
    J Invest Dermatol; 1987 Feb; 88(2):233-7. PubMed ID: 3100656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
    McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK
    Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
    Margolick JB; Volkman DJ; Folks TM; Fauci AS
    J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity of HIV in lymphatic organs of patients with AIDS.
    Pekovic DD; Gornitsky M; Ajdukovic D; Dupuy JM; Chausseau JP; Michaud J; Lapointe N; Gilmore N; Tsoukas C; Zwadlo G
    J Pathol; 1987 May; 152(1):31-5. PubMed ID: 3305846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of the HTLV-II-bearing T-cell line C3 with HTLV-III/LAV is highly permissive and lytic.
    Montefiori DC; Mitchell WM
    Virology; 1986 Dec; 155(2):726-31. PubMed ID: 3024409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
    Harada S; Koyanagi Y; Yamamoto N
    Science; 1985 Aug; 229(4713):563-6. PubMed ID: 2992081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.
    Schüpbach J; Popovic M; Gilden RV; Gonda MA; Sarngadharan MG; Gallo RC
    Science; 1984 May; 224(4648):503-5. PubMed ID: 6200937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.
    Blumberg RS; Sandstrom EG; Paradis TJ; Neumeyer DN; Sarngadharan MG; Hartshorn KL; Byington RE; Hirsch MS; Schooley RT
    J Clin Microbiol; 1986 Jun; 23(6):1072-7. PubMed ID: 2423552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Dalgleish AG; Beverley PC; Clapham PR; Crawford DH; Greaves MF; Weiss RA
    Nature; 1984 Dec 20-1985 Jan 2; 312(5996):763-7. PubMed ID: 6096719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological properties of HTLV-III/LAV: a possible pathway of natural infection in vivo.
    Popovic M; Read-Connole E; Gartner S
    Ann Inst Pasteur Immunol; 1986; 137D(3):413-7. PubMed ID: 2950906
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.
    Sugamura K; Fujii M; Kannagi M; Sakitani M; Takeuchi M; Hinuma Y
    Int J Cancer; 1984 Aug; 34(2):221-8. PubMed ID: 6088403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.